It has also been shown that miRNA-126-3p down-regulation contributes to dabrafenib-acquired resistance in melanoma patients by up-regulating ADAM9 (ADAM Metallopeptidase Domain 9) and VEGFA (28). This evidence concerns the gene ADAM9 and melanoma.